{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:43:12Z","timestamp":1784562192456,"version":"3.55.0"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Guangzhou Municipal Science and Technology Plan Project","award":["202102020804"],"award-info":[{"award-number":["202102020804"]}]},{"name":"State Key Laboratory of Drug Regulatory Science Project","award":["2023SKLDRS0111"],"award-info":[{"award-number":["2023SKLDRS0111"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Currently, the integrity of rabies virus particle in quality control can only be assessed through electron microscopy. However, its time-consuming nature, operational complexity, limited accuracy and lack of quantification capability no longer meet the needs of modern vaccine production. Based on this, we developed a time-resolved fluoroimmunoassay (TRFIA) to enable real-time quantitative analysis of rabies virus particle integrity in human rabies vaccine, by detecting exposed nucleoprotein. Monoclonal antibodies against rabies glycoprotein and nucleoprotein were prepared using the classical hybridoma technology with the aim of constructing a novel detection approach for assessing particle integrity. A monoclonal antibody against rabies glycoprotein was immobilized on microplate wells to capture rabies virus particles, while a labeled antibody against the nucleoprotein served as the signal tracer. Multiple types of vaccine samples were analyzed to evaluate the effectiveness and accuracy of the developed TRFIA, combined with various virus particle destruction methods to validate its capability to assess particle integrity. The validation results were consistent with those obtained from electron microscopy. Therefore, this novel TRFIA offers a promising solution to address existing gaps in current analytical methods, enabling straightforward real-time, and quantitative evaluation of rabies virus particle integrity in the laboratory.<\/jats:p>","DOI":"10.1371\/journal.pntd.0013077","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T17:52:17Z","timestamp":1748627537000},"page":"e0013077","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exposed nucleoprotein inside rabies virus particle as an ideal target for real-time quantitative evaluation of rabies virus particle integrity in vaccine quality control"],"prefix":"10.1371","volume":"19","author":[{"given":"Jia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuangrou","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouchun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingsong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1150-9625","authenticated-orcid":true,"given":"Guanfeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"1","key":"pntd.0013077.ref001","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41541-024-00925-w","article-title":"Safety and efficacy assessment of an mRNA rabies vaccine in dogs, rodents, and cynomolgus macaques","volume":"9","author":"J Li","year":"2024","journal-title":"NPJ Vaccines"},{"key":"pntd.0013077.ref002","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jama.2022.22254","article-title":"Rabies","volume":"329","author":"J Jin","year":"2023","journal-title":"JAMA"},{"issue":"51","key":"pntd.0013077.ref003","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1016\/j.vaccine.2021.10.060","article-title":"A chemiluminescence immunoassay for precise automatic quality control of glycoprotein in human rabies vaccine","volume":"39","author":"K Ye","year":"2021","journal-title":"Vaccine"},{"key":"pntd.0013077.ref004","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jviromet.2014.06.002","article-title":"A time-resolved fluoroimmunoassay for the quantitation of rabies virus nucleoprotein in the rabies vaccine","volume":"206","author":"G Lin","year":"2014","journal-title":"J Virol Methods"},{"key":"pntd.0013077.ref005","article-title":"Special issue \u201cadvances in rabies research\u201d","volume":"15","author":"SA Nadin-Davis","year":"2023","journal-title":"Viruses"},{"issue":"5","key":"pntd.0013077.ref006","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(22)00641-7","article-title":"Human rabies despite post-exposure prophylaxis: a systematic review of fatal breakthrough infections after zoonotic exposures","volume":"23","author":"ER Whitehouse","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"pntd.0013077.ref007","doi-asserted-by":"crossref","DOI":"10.3390\/v16010160","article-title":"Human rabies treatment-from palliation to promise","volume":"16","author":"M Lacy","year":"2024","journal-title":"Viruses"},{"issue":"32","key":"pntd.0013077.ref008","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1016\/j.vaccine.2022.06.035","article-title":"Safety and immunogenicity of human rabies vaccine for the Chinese population after PEP: A systematic review and meta-analysis","volume":"40","author":"L Wang","year":"2022","journal-title":"Vaccine"},{"key":"pntd.0013077.ref009","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12250-019-00157-6","article-title":"Proteomic profiling of purified rabies virus particles","volume":"35","author":"Y Zhang","year":"2020","journal-title":"Virol Sin"},{"key":"pntd.0013077.ref010","doi-asserted-by":"crossref","first-page":"1288879","DOI":"10.3389\/fimmu.2023.1288879","article-title":"An mRNA vaccine against rabies provides strong and durable protection in mice","volume":"14","author":"M Li","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"pntd.0013077.ref011","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1038\/s41598-021-82766-4","article-title":"Publisher Correction: Rabies Vaccine Characterization by Nanoparticle Tracking Analysis","volume":"11","author":"ME Navarro Sanchez","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"pntd.0013077.ref012","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2019","article-title":"Virus detection by transmission electron microscopy: Still useful for diagnosis and a plus for biosafety","volume":"29","author":"P Roingeard","year":"2019","journal-title":"Rev Med Virol"},{"key":"pntd.0013077.ref013","doi-asserted-by":"crossref","first-page":"114752","DOI":"10.1016\/j.jviromet.2023.114752","article-title":"A custom-made time-resolved fluoroimmunoassay for the quantitation of the host cell protein of Vero in rabies vaccine","volume":"318","author":"Y Yang","year":"2023","journal-title":"J Virol Methods"},{"issue":"41","key":"pntd.0013077.ref014","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1016\/j.vaccine.2019.08.043","article-title":"Rabies virus glycoprotein serology ELISA for measurement of neutralizing antibodies in sera of vaccinated human subjects","volume":"37","author":"R Zhao","year":"2019","journal-title":"Vaccine"},{"key":"pntd.0013077.ref015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ab.2014.05.004","article-title":"Residual bovine serum albumin (BSA) quantitation in vaccines using automated capillary western technology","volume":"461","author":"JW Loughney","year":"2014","journal-title":"Anal Biochem"},{"key":"pntd.0013077.ref016","article-title":"A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency","volume":"7","author":"G Lin","year":"2017","journal-title":"Sci Rep"},{"key":"pntd.0013077.ref017","doi-asserted-by":"crossref","first-page":"113518","DOI":"10.1016\/j.jim.2023.113518","article-title":"A time-resolved fluorescence immunoassay for rapid and precise automatic quality control of human papillomavirus type 68 VLPs in human papillomavirus vaccine","volume":"519","author":"Z Li","year":"2023","journal-title":"J Immunol Methods"},{"key":"pntd.0013077.ref018","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biologicals.2020.08.008","article-title":"A time-resolved fluoroimmunoassay for assessing rabies antibody titers in the sera of vaccinated human subjects","volume":"68","author":"L Bian","year":"2020","journal-title":"Biologicals"},{"issue":"12","key":"pntd.0013077.ref019","article-title":"Novel envelope protein time-resolved fluoroimmunoassay as an alternative in vitro potency assay for quality control of inactivated Japanese encephalitis virus vaccine","volume":"10","author":"Z Li","year":"2024","journal-title":"Heliyon"},{"issue":"11","key":"pntd.0013077.ref020","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.3390\/v14112388","article-title":"Concentration of SARS-CoV-2-Infected Cell Culture Supernatants for Detection of Virus-like Particles by Scanning Electron Microscopy","volume":"14","author":"M Le Bideau","year":"2022","journal-title":"Viruses"},{"key":"pntd.0013077.ref021","article-title":"Effect of postmortem degradation on the preservation of viral particles and rabies antigens in mice brains light and electron microscopic study","volume":"12","author":"J MonroyGomez","year":"2020","journal-title":"Viruses"},{"issue":"8","key":"pntd.0013077.ref022","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1099\/jgv.0.001269","article-title":"Trying to treat the untreatable: experimental approaches to clear rabies virus infection from the CNS","volume":"100","author":"SP Smith","year":"2019","journal-title":"J Gen Virol"},{"issue":"3","key":"pntd.0013077.ref023","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2019.12.012","article-title":"Structural Analysis of Rabies Virus Glycoprotein Reveals pH-Dependent Conformational Changes and Interactions with a Neutralizing Antibody","volume":"27","author":"F Yang","year":"2020","journal-title":"Cell Host Microbe"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T17:52:29Z","timestamp":1748627549000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013077"}},"subtitle":[],"editor":[{"given":"Prashant","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013077","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}